EIF2S3
protein-codingeukaryotic translation initiation factor 2 subunit gamma
Gene summary
The protein encoded by this gene is the largest subunit of a heterotrimeric GTP-binding protein involved in the recruitment of methionyl-tRNA(i) to the 40 S ribosomal subunit. [provided by RefSeq, Jan 2010]
- EIF2G
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~23.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: Genomics England PanelApp
Inheritance Pattern: XL
Disease ID:MONDO:0005015
Submitter: Genomics England PanelApp
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010258
Submitter: ClinGen
The *EIF2S3* gene encodes the γ subunit of eukaryotic translation initiation factor-2 (eIF2), a heterotrimeric GTP-binding protein involved in the recruitment of methionyl-tRNA(i) to the 40S ribosomal subunit. The acronym MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity) was coined by Steinmuller et al. (PMID: 9781023) who described a large three-generation family with five affected boys and mapped the disease locus to the short arm of chromosome X. Using chromosome X-exome sequencing, Skopkova et al. (2017) identified a frameshift mutation, I465Sfs, in *EIF2S3* in an affected male in the family reported by Steinmüller et al. (1998). Functional assays using a yeast/human (Sc/Hs) chimeric form of eIF2γ in yeast demonstrated the variant impairs eIF2γ function. The same variant was also detected in other 3 unrelated families with typical MEHMO syndrome features in affected males. Sequencing data suggested a founder effect for this variant (PMIDs: 27333055, 28055140, 29303605). Five missense mutations, which exhibited reduced growth rate and/or impaired translation function in yeast, were also reported in male patients exhibiting either typical features of MEHMO or milder phenotypes with a subset of MEHMO features, supporting variable clinical expressivity of MEHMO in patients with deleterious *EIF2S3* variants (PMIDs: 23063529, 27333055, 30878599, 32799315). The association is seen in 14 probands in 6 publications (PMID: 27333055, 28055140, 23063529, 29303605, 30878599, 32799315). The mechanism for disease is expected to be hemizygous loss of function. All reported female carriers are asymptomatic. Morpholino-based knockdown of the zebrafish *EIF2S3* ortholog recapitulates the human microcephaly and short stature phenotype (PMID: 27333055). An *EIF2S3* knockdown human pancreatic β cell line showed impaired cell survival and increased caspase activities (PMID: 30878599). In summary, the *EIF2S3*/MEHMO syndrome gene-disease relationship is definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 11, 2021 (SOP version 8).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic
Intervention: Endocrine
Rationale: Awareness of endocrine manifestations, including growth hormone deficiency and hypogonadism, may allow early recognition and treatment
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EIF2S3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001415.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 14 | 2 | 33 | ||
| missense | 3 | 6 | 74 | 1 | 84 | |
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 31 | 31 | ||||
| Total | 3 | 7 | 127 | 15 | 2 | 154 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001406.1 | 12 | MANE Select | |
| Ensembl | ENSP00000253039.4 | 12 | MANE Select | |
| Ensembl | ENSP00000391383.1 | 5 | Standard | |
| Ensembl | ENSP00000534874.1 | 12 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| eif2s3 | Danio rerio | Structure: trunk Quality: necrotic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RNA transport - Homo sapiens (human)
- Translation Factors
- double stranded rna induced gene expression
- skeletal muscle hypertrophy is regulated via akt-mtor pathway
- Formation of the ternary complex, and subsequently, the 43S complex
Biological Process
- formation of translation preinitiation complex
- translational initiation
- transmembrane transport
Molecular Function
- translation initiation factor activity
- GTPase activity
- protein binding
- GTP binding
- translation factor activity, RNA binding
Cellular Component
- nucleus
- cytoplasm
- cytosol
- eukaryotic translation initiation factor 2 complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000253039
- Coding exons
- 12
- Length
- 23256
- Individuals with no LoFs
- 125716
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125737
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.61 | 42 | 177 | 0.237 | 0.0000130 | 3052 |
| Missense (PolyPhen) | 0 | 44.217 | 0 | 855 | ||
| Synonymous | -0.130 | 63 | 61.7 | 1.02 | 0.00000462 | 944 |
| Loss of Function | 3.32 | 1 | 14.7 | 0.0678 | 0.00000100 | 295 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00025 | rare |
| Latino/Admixed American | 0.000081 | 0.000058 | rare |
| Ashkenazi Jewish | 0.00014 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00019 | 0.00014 | rare |
| European (Non-Finnish) | 0.00013 | 0.000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00024 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: As a subunit of eukaryotic initiation factor 2 (eIF2), involved in the early steps of protein synthesis. In the presence of GTP, eIF2 forms a ternary complex with initiator tRNA Met-tRNAi and then recruits the 40S ribosomal complex, a step that determines the rate of protein translation. This step is followed by mRNA binding to form the 43S pre-initiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex. In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF2B (By similarity). Along with its paralog on chromosome Y, may contribute to spermatogenesis up to the round spermatid stage (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q9Z0N1}.;
Recessive Scores
- pRec
- 0.218
Intolerance Scores
- LoFtool
- 0.117
- RVIS EVS
- 0.13
- RVIS percentile EVS
- 62.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.973
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |